Characteristic | Total (%) n (%) (n=53) | Peer-reviewed articles/abstracts n (%) (n=42) | Grey literature n (%) (n=11) |
Region | |||
East Asia and Pacific | 5 (9.4) | 5 (11.9) | 0 (0.0) |
Europe and Central Asia | 2 (3.8) | 2 (4.8) | 0 (0.0) |
Latin America and Caribbean | 16 (30.2) | 13 (40.0) | 3 (27.3) |
Middle East and North Africa | 14 (26.4) | 13 (40.0) | 1 (9.1) |
South Asia | 4 (7.5) | 2 (4.8) | 2 (18.2) |
Sub-Saharan Africa | 12 (22.6) | 7 (16.7) | 5 (45.5) |
Year of publication | |||
1999–2009 | 4 (7.5) | 2 (4.8) | 2 (18.2) |
2010–2013 | 5 (9.4) | 3 (7.1) | 2 (18.2) |
2014–2015 | 10 (18.9) | 7 (16.7) | 3 (27.3) |
2016–2017 | 13 (24.5) | 12 (28.6) | 1 (9.1) |
2018–2019 | 21 (39.6) | 18 (42.9) | 3 (27.3) |
Methodology | |||
Qualitative | 25 (47.2) | 18 (42.9) | 7 (63.6) |
Quantitative | 27 (50.9) | 24 (57.1) | 3 (27.3) |
Mixed methods | 1 (1.9) | 0 (0.0) | 1 (9.1) |
Study design* | |||
Cross-sectional survey | 19 (35.8) | 15 (35.7) | 4 (36.4) |
Chart review | 8 (15.1) | 8 (19.0) | 0 (0.0) |
Other quantitative design† | 2 (3.8) | 2 (4.8) | 0 (0.0) |
Qualitative interviews/focus groups | 25 (47.2) | 18 (42.9) | 8 (72.7) |
Recruitment approach* | |||
Community based | 29 (54.7) | 20 (47.6) | 10 (90.9) |
Clinic based | 20 (37.7) | 20 (47.6) | 0 (0.0) |
Online | 5 (9.4) | 4 (9.5) | 1 (9.1) |
Trans men sample size, quantitative studies (n=28) | |||
≤50 | 18 (64.3) | 14 (58.3) | 4 (100.0) |
51–100 | 4 (14.3) | 4 (16.7) | 0 (0.0) |
101–150 | 2 (7.1) | 2 (8.3) | 0 (0.0) |
151–200 | 2 (7.1) | 2 (8.3) | 0 (0.0) |
500+ | 2 (7.1) | 2 (8.3) | 0 (0.0) |
Health domains* | |||
Gender-affirming care | 25 (47.1) | 22 (52.4) | 3 (27.3) |
General physical health | 5 (9.4) | 4 (9.5) | 1 (9.1) |
Healthcare access | 10 (18.9) | 7 (16.7) | 3 (27.3) |
Mental health | 17 (32.1) | 15 (35.7) | 2 (18.2) |
Sexual and reproductive health | 13 (24.5) | 8 (19.0) | 5 (45.5) |
Social determinants of health | 26 (49.1) | 17 (40.5) | 9 (81.8) |
Substance use | 5 (9.4) | 5 (11.9) | 0 (0.0) |
*Multiple responses possible; frequencies may not sum to 100%.
†Longitudinal cohort; clinical interviews.